Medindia LOGIN REGISTER
Medindia

Side effect(s) of Sofosbuvir, Velpatasvir, and Voxilaprevir


Review the side-effects of Sofosbuvir, Velpatasvir, and Voxilaprevir as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.

If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.

  Common:
Diarrhea, nausea, headache, tiredness or asthenia

  Cardiovascular:
Slow heartbeat (in patients taking amiodarone)

  Nervous system:
Inability to sleep, depression

  Skin:
Rashes, angioedema, blisters

  Others:
Raised bilirubin, serum lipase, and creatine kinase levels

Other Precautions :

• An overdose of sofosbuvir, velpatasvir, and voxilaprevir is treated symptomatically as no specific antidote is available.
• Do not share razors, needles or have unprotected sex as sofosbuvir, velpatasvir, and voxilaprevir tablets will not prevent from spreading hepatitis C virus.
• Caution is required while using sofosbuvir, Velpatasvir, and Voxilaprevir tablets in pregnant women or breastfeeding mothers.
• Do not take an extra dose to make up the missed dose. Take the missed dose immediately when you remember or skip the dose if it is too close to the next scheduled dose.

Drug Name : Sofosbuvir, Velpatasvir, and Voxilaprevir

Sofosbuvir, Velpatasvir, and Voxilaprevir generic The sofosbuvir, velpatasvir and voxilaprevir combination is the first pan-genotypic fixed-dose combination drug prescribed to treat adult patients who suffer from genotype 1-6 chronic HCV infection without cirrhosis or with compensated cirrhosis (Child-Pugh A). This fixed dose combination is used only when other treatments showed a poor response or have failed. More precisely, it is used in- • Patients who were earlier treated with a combination of drugs that included an NS5A inhibitor• Patients with genotype 1a or 3 infection and have previously been treated with a combination of drugs containing sofosbuvir but without an NS5A inhibitor This combination works by preventing the multiplication of the hepatitis C virus inside the body.


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education